Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 14, 2025
Global Naloxone Market to Witness Remarkable Growth with Indivior PLC, Akorn, Inc., Hikma Pharmaceuticals PLC, Purdue
EIN Presswire
·
March 14, 2025
BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- The Global Naloxone Market is expected to grow at 10.4% CAGR from 2025 to 2032. The Latest study titled Naloxone Market 2025, published by Coherent Market Insights, provides valuable …
Pharmaceutical Intermediates Market Poised for Significant Growth with Advancements in Drug Development | CAGR of 8.3%
EIN Presswire
·
March 14, 2025
BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- The pharmaceutical intermediates market is estimated to be valued at USD 47.30 Bn in 2025 and is expected to reach USD 82.70 Bn by 2032, growing at a compound annual growth rate (CAGR) …
US Transthyretin Amyloidosis Treatment Market Rising Growth Due to Advancements in Rare Disease Therapies with CAGR 9.6%
EIN Presswire
·
March 14, 2025
BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- The U.S. transthyretin amyloidosis treatment market is estimated to be valued at USD 65.4 Mn in 2025 and is expected to reach USD 124.4 Mn by 2032, exhibiting a compound annual growth …
Interventional Radiology Market Booming with Technological Innovations in Minimally Invasive Procedures with a 6.9% CAGR
EIN Presswire
·
March 14, 2025
BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- The global interventional radiology market is estimated to be valued at USD 28.83 Bn in 2025 and is expected to reach USD 46.03 Bn by 2032, exhibiting a compound annual growth rate (CAGR …
Healthcare Integrated Technologies Inc. Successfully Raises $10 million in Friends & Family Funding
GlobeNewswire
·
March 14, 2025
Knoxville, TN, March 14, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the successful completion of a $10 million capital raise as part of …
Brooks Pediatric Dentistry & Orthodontics Launches FOREVERSMILE, a Retainer Assurance Program
EIN Presswire
·
March 14, 2025
Introducing a groundbreaking initiative to ensure lasting smiles for orthodontic patients with the new FOREVERSMILE program. SAN ANTONIO, TX, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Brooks Pediatric Dentistry …
Real World Data (RWD) Market Projected To Witness Substantial Growth, 2025-2032: IBM Corporation, Tempus Labs Inc.
EIN Presswire
·
March 14, 2025
Real World Data (RWD) Market size is projected to grow from US$ 1.59 Bn in 2023 to US$ 4.07 Bn by 2030, at a CAGR of 14.4% BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Latest Report, titled “Real-world Data (RWD) Market” Trends, …
Stone Oak Children's Dentistry & Orthodontics Proudly Sponsors Local School PTAs to Enhance Educational Opportunities
EIN Presswire
·
March 14, 2025
Stone Oak Children's Dentistry sponsors four local PTAs, supporting the Stone Oak community and students SAN ANTONIO, TX, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Stone Oak Children's Dentistry …
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation
GlobeNewswire
·
March 14, 2025
Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency (“RF”) Generator On track for Investigational Device Exemption (“IDE”) submission and, if approved, U.S. clinical …
Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108
GlobeNewswire
·
March 14, 2025
Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts support safety and tolerability of PALI-2108 No serious adverse events (SAEs) and no treatment-emergent adverse …
25% Fatality Rate in Definite Healthcare-Associated Legionnaires' Disease Cases
EIN Presswire
·
March 14, 2025
Chemstar WATER tackles hospital water safety with cutting-edge solutions, reducing Legionnaires' disease risks and operational costs. MD, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Chemstar WATER, a leading commercial water treatment company, …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
March 14, 2025
SOUTH SAN FRANCISCO, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
GlobeNewswire
·
March 14, 2025
SAN JOSE, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will …
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
GlobeNewswire
·
March 14, 2025
CAMBRIDGE, Mass., March 14, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, …
Nuvectis Pharma to Participate in the 37th Annual Roth Conference
GlobeNewswire
·
March 14, 2025
FORT LEE, NJ, March 14, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in …
Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025
GlobeNewswire
·
March 14, 2025
SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 31, 2025, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter …
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
GlobeNewswire
·
March 14, 2025
BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Iridex Comments on Recent Stock Price Volatility
GlobeNewswire
·
March 14, 2025
MOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases, today …
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
GlobeNewswire
·
March 14, 2025
- Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study - - Company expects to submit New Drug Application (NDA) in April 2025 - DEER PARK, Ill., March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” …
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
GlobeNewswire
·
March 14, 2025
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME) ANI plans to begin marketing ILUVIEN in the U.S. under the combined label later this …